Malaria drug combo under scrutiny: could tafenoquine interact?
NCT ID NCT07060794
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a malaria drug called tafenoquine interacts with two other common malaria treatments (DHA-piperaquine and artesunate-pyronaridine) in adults with vivax malaria. About 507 participants will receive one of the combinations or a delayed treatment to compare safety and how well they prevent the parasite from returning. The goal is to find the best way to combine these drugs for effective malaria control.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VIVAX MALARIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.